Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Global Water Resources
GWRS
$206M
| $2.26M | ﹤0.01% |
120,756
-5,827
| -5% | -$108K |
|
|
DS
3227
DELISTED
Drive Shack Inc.
DS
| $2.25M | ﹤0.01% |
801,955
-25,578
| -3% | -$68.8K |
|
3228
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
| $2.24M | ﹤0.01% |
47,695
+11,865
| +33% | +$574K |
|
3229
InfuSystem Holdings
INFU
$184M
| $2.24M | ﹤0.01% |
171,793
-4,315
| -2% | -$70.4K |
|
|
CBAY
3230
DELISTED
Cymabay Therapeutics
CBAY
| $2.23M | ﹤0.01% |
612,482
-25,744
| -4% | -$101K |
|
3231
Weatherford International
WFRD
$6.29B
| $2.23M | ﹤0.01% |
113,166
+98,408
| +667% | +$1.64M |
|
3232
Beam Global
BEEM
$23.3M
| $2.22M | ﹤0.01% |
80,994
-2,565
| -3% | -$76.3K |
|
|
SURF
3233
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $2.22M | ﹤0.01% |
292,769
+6,068
| +2% | +$38.8K |
|
3234
Flexsteel Industries
FLXS
$302M
| $2.21M | ﹤0.01% |
71,600
-2,462
| -3% | -$87.8K |
|
3235
Dianthus Therapeutics
DNTH
$5.84B
| $2.2M | ﹤0.01% |
18,900
-1,020
| -5% | -$119K |
|
|
SEEL
3236
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $2.2M | ﹤0.01% |
238
+40
| +20% | +$344K |
|
|
PVBC
3237
DELISTED
Provident Bancorp
PVBC
| $2.2M | ﹤0.01% |
137,181
-13,335
| -9% | -$215K |
|
3238
iShares Core S&P US Growth ETF
IUSG
$31.7B
| $2.2M | ﹤0.01% |
21,444
+428
| +2% | +$45.2K |
|
|
ICAD
3239
DELISTED
iCAD Inc
ICAD
| $2.19M | ﹤0.01% |
203,768
-11,418
| -5% | -$149K |
|
3240
eGain
EGAN
$187M
| $2.19M | ﹤0.01% |
214,371
-9,435
| -4% | -$107K |
|
|
GHL
3241
DELISTED
Greenhill & Co., Inc.
GHL
| $2.18M | ﹤0.01% |
149,036
-9,303
| -6% | -$138K |
|
|
AWH
3242
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $2.18M | ﹤0.01% |
44,683
-3,523
| -7% | -$218K |
|
|
LTRPA
3243
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $2.18M | ﹤0.01% |
704,713
-39,404
| -5% | -$147K |
|
3244
iShares US Real Estate ETF
IYR
$4.66B
| $2.17M | ﹤0.01% |
21,219
-50
| -0.2% | -$5.32K |
|
|
ZY
3245
DELISTED
Zymergen Inc. Common Stock
ZY
| $2.17M | ﹤0.01% |
164,678
-24,556
| -13% | -$521K |
|
3246
Schwab US Large- Cap ETF
SCHX
$71.8B
| $2.17M | ﹤0.01% |
124,956
+1,200
| +1% | +$21.4K |
|
|
CASA
3247
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $2.16M | ﹤0.01% |
318,829
-27,163
| -8% | -$201K |
|
3248
Cardiff Oncology
CRDF
$66.5M
| $2.16M | ﹤0.01% |
323,706
+5,861
| +2% | +$36.8K |
|
|
NEXI
3249
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $2.15M | ﹤0.01% |
5,693
+2,935
| +106% | +$984K |
|
3250
Fortress Biotech
FBIO
$104M
| $2.15M | ﹤0.01% |
44,588
-3,272
| -7% | -$160K |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.